1-5 of 5
Antonia Cladera, MD
Close
Sort by
Journal Articles

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Eulalia Genesca, PhD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Pere Barba, MD, Cristina Gil, MD PhD, Ramon Guàrdia, MD, Maria Jose Moreno, MD, Daniel Martínez-Carballeira, MD, Irene García-Cadenas, Susana Vives, MD, Jordi Ribera, José González-Campos, MD, Marina Diaz-Beyá, MD, Santiago Mercadal, MD, Maria Teresa Artola, MD, Antonia Cladera, MD, Mar Tormo, MD PhD, Arancha Bermudez, MD, Ferran Vall-Llovera, MD, Pilar Martinez, MD, María-Luz Amigo, MD, Juan-Miguel Bergua, MD, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Silvia Monsalvo, Andrés Novo, MD, Marta Cervera, MD, Antonio Garcia-Guiñon, MD, Jordi Junca, MD, Juana Ciudad, PhD, Alberto Orfao, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2018-99-114559
Published: 2018
Journal Articles

Comparison of Efficacy and Safety of Two Types of E.coli Asparaginase (Native or Pegylated) for Treatment of Adult Patients with High-Risk (HR), Philadelphia (Ph) Chromosome-Negative ALL Included in the Prospective MRD-Oriented Protocol ALL-HR-11 from the Spanish Pethema Group

Josep-Maria Ribera, MD PhD, Mireia Morgades, MProbS, Pau Montesinos, MD PhD, Irene García-Cadenas, MD, Pere Barba, MD PhD, Beatriz Soria, MD, Arancha Bermúdez, MªJosé Moreno, MD, José González-Campos, MD, Susana Vives, MD, Cristina Gil, MD, Eugenia Abella, MD PhD, Ramon Guàrdia, MD PhD, Teresa Bernal, MD PhD, Pilar Martínez-Sánchez, MD, MªLuz Amigo, MD, Santiago Mercadal, MD, Alfons Serrano, MD, Aurelio López-Martínez, MD, Ferran Vall-llovera, MD, MªJosé Sánchez-Sánchez, MD, MªJesús Peñarrubia, MD PhD, María Calbacho, MD, Jose-Angel Méndez, MD, Juan Bergua, MD, Antònia Cladera, MD, Mar Tormo, MD, Daniel García-Belmonte, MD, Juana Ciudad, MD PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2016) 128 (22): 180.
https://doi.org/10.1182/blood.V128.22.180.180
Published: 2016
Journal Articles

Incidence, Treatment and Prognosis of Patients with Relapsed Burkitt Lymphoma/Leukemia Treated with Specific Chemotherapy or Immunochemotherapy in Spain

Alberto Pineda, MD, Juan-Manuel Sancho, MD PhD, Olga Garcia, MD, Jordi Esteve, MD PhD, Mar Tormo, MD PhD, Pilar Martinez, MD, Ferran Vall-llovera, MD, Rodrigo Martino, MD PhD, Pau Montesinos, MD, Jose Gonzalez-Campos, MD, Juan Bergua, María Calbacho, MD, Cristina Gil, MD, Ana Vicent, MD, Antònia Cladera, MD, Jesus Hernandez, MD, Maria-José Moreno, MD, Alfons Serrano, MD, Natalia Alonso, MD, Raimundo García, MD, Pere Barba, MD PhD, Angeles Fernandez, MD, Pilar Miralles, MD PhD, Andrés Novo, MD, Jose Maria Moraleda, MDPhD, José Ángel Hernández, MD, Eugenia Abella, MD PhD, Magdalena Sanchez, MD, Maria-Elsa Lopez, MD, Teresa Bernal, MD, Mª Carmen Mateos, MD, Esperanza Lavilla, MD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2723.
https://doi.org/10.1182/blood.V126.23.2723.2723
Published: 2015
Journal Articles

Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD). Preliminary Results of the Pethema ALL-HR-11 Trial

Josep-Maria Ribera, MD PhD, Mireia Morgades, MD, Juana Ciudad, MD PhD, Pere Barba, MD PhD, Rodrigo Martino, MD PhD, Pau Montesinos, MD PhD, Susana Vives, MªJosé Moreno, MD, Beatriz Soria, MD, Cristina Gil, MD, José González-Campos, MD, MªLuz Amigo, MD, Andrés Novo, MD, Mar Tormo, MD PhD, Arancha Bermúdez, MD, Alfons Serrano, MD, Teresa Bernal, MD, Aurelio López, Juan Bergua, Lourdes Escoda, MD PhD, Pilar Martínez, MD, Natalia Alonso, MD, Santiago Mercadal, MD, Eugenia Abella, MD PhD, Ramon Guàrdia, MD PhD, Ferran Vall-llovera, MD, Antònia Cladera, MD, Jordi Esteve, MD PhD, Raimundo García-Boyero, MD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1333.
https://doi.org/10.1182/blood.V126.23.1333.1333
Published: 2015
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Classical Risk Factors and Minimal Residual Disease (MRD). Interim Results of the PETHEMA ALL-AR-03 Trial.

Josep Ribera, MD, Albert Oriol, MD, Mireia Morgades, MD, Josep Sarrá, MD, Salut Brunet, MD, Andreu Llorente, MD, Ramon Guardia, MD, Ricardo Parody, MD, Teresa Bernal, MD, Jordi Esteve, MD, Miguel Sanz, MD, Eloy Del Potro, MD, Juan Bergua, MD, Maria-Jose Moreno, MD, Carlos Grande, MD, Javier Bueno, MD, Antonia Cladera, MD, María-Carmen Fernández, MD, Raimundo García-Boyero, MD, Arancha Bermúdez, MD, Evarist Feliu, MD
Journal: Blood
Blood (2006) 108 (11): 1872.
https://doi.org/10.1182/blood.V108.11.1872.1872
Published: 2006